Want to join the conversation?
In Specialty Generics, $MNK said net sales were down 14% vs. previous year's historical highs. On the business development front, the company said, it continues to be active in optimizing its commercial and development portfolio. The key areas of focus remain building on its specialty brands growth platform and the specialty generics business.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.